Care Plans for life sciences
Patient programmes that live inside the pathway
Adherence measured where it happens, not surveyed afterwards. A sponsor co-funds the pathway the clinic and the patient already use.
- The same product the clinic uses
- Measured inside the pathway
- Never patient-identifiable
2,400 patients
enrolled across five programmes
68% to 87%
steps completed on time
What a sponsor co-funds
One product, three views. This is the sponsor's side.
Adherence, where it happens
Steps completed, appointments kept, refills collected. From the pathway itself rather than from self-report.
Decision to first dose
The interval most initiation programmes lose patients in, measurable step by step.
Time to diagnosis, assembled
Referrals, tests and waits are recorded individually and never joined. Here they are joined, anonymised, into one measurable journey.
What a sponsor never receives
Anything patient-identifiable. What arrives is anonymised and aggregated, and it is stated per programme.
Programmes running today
With the centres, the patients enrolled and the measured result.
- Multiple sclerosis: the first Care Plan, built with the centres that run the pathway.
- Dementia, colorectal, cardiac ablation, obesity: the launch set.
| Programme | Centres | Patients enrolled | Measured result |
|---|---|---|---|
| Multiple sclerosis | 4 neurology centres, Slovakia | 910 | Scheduled steps completed on time rose from 68% to 87% over 12 months |
| Dementia | 2 centres, Slovakia | 260 | Carer tasks completed on time, 79% over 6 months |
| Colorectal | 3 centres, Slovakia and Czechia | 480 | Median time from referral to first appointment fell from 21 to 9 days |
| Cardiac ablation | 1 centre, Slovakia | 210 | Follow-up appointments kept, 92% over 6 months |
| Obesity | 2 centres, Slovakia | 540 | Programme retention at 6 months, 74% |
Monthly briefing
The signal, once a month.
What changed in European health data, what we shipped, and what it means for a provider. Nothing else.